Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oluwafemi Akintola has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew James Bennet

    Department of Chemistry, Simon Fraser University, Burnaby, BC V5A 1S6, Canada

    5 shared publications
  • Robert Britton

    Department of Chemistry Simon Fraser University Burnaby BC V5A 1S6 Canada

    3 shared publications
  • Weiwu Ren

    Molecular Synthesis Center & Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy Ocean University of China Qingdao China

    3 shared publications
  • Marco Farren-Dai

    Department of Chemistry, Simon Fraser University, Burnaby, British ColumbiaV5A 1S6, Canada

    2 shared publications
  • Pal John Pal Adabala

    Department of Chemistry, Simon Fraser University, 8888 University Drive, Burnaby, British Columbia V5A 1S6, Canada

    2 shared publications
  • Saeideh Shamsi Kazem Abadi

    Department of Molecular Biology and Biochemistry, Simon Fraser University, 8888 University Drive, Burnaby, British Columbia V5A 1S6, Canada

    2 shared publications

Latest Publications

  • Open Access

    Mechanism-Based Allylic Carbasugar Chlorides That Form Covalent Intermediates with α- and β-Galactosidases

    by Oluwafemi Akintola, Sandeep Bhosale, Andrew J. Bennet

    Glycoside hydrolases have been implicated in a wide range of human conditions including lysosomal storage diseases. Consequently, many researchers have directed their efforts towards identifying new classes of glycoside hydrolase inhibitors, both synthetic and from natural sources. A large percentage of such inhibitors are reversible competitive inhibitors that bind in the active site often due to them possessing structural features, often a protonatable basic nitrogen atom, that mimic the enzymatic transition state. We report that mechanism-based small molecule galacto-like configured cyclohexenyl carbasugars form reversible covalent complexes with both α-galactosidase and β-galactosidase. In addition, we show that the β-galactosidase from Aspergillus oryzae reacts with three different carbasugar inhibitors, with three different second-order rate constants (kinact/Ki), to give the same enzyme–carbasugar covalent intermediate. The surprising observation that the α-galacto-configured inhibitor covalently labels the A. oryzae β-galactosidase highlights the catalytic versatility of glycoside hydrolases. We expect that cyclohexenyl covalent inhibitors will become an important class of compounds in the chemical biologist’s tool box.


  • Glycoside Hydrolase Catalysis: Do Substrates and Mechanism-Based Covalent Inhibitors React via Matching Transition States?

    by Oluwafemi Akintola, Marco Farren-Dai, Weiwu Ren, Sandeep Bhosale, Robert Britton, Katarzyna Świderek, Vicent Moliner, Andrew J. Bennet


  • Open Access

    Intrinsic Nucleophilicity of Inverting and Retaining Glycoside Hydrolases Revealed Using Carbasugar Glyco-Tools

    by Oluwafemi Akintola, Weiwu Ren, Pal John Pal Adabala, Sandeep Bhosale, Yang Wang, Yumeela Ganga-Sah, Robert Britton, Andrew J. Bennet


  • Conformationally Controlled Reactivity of Carbasugars Uncovers the Choreography of Glycoside Hydrolase Catalysis

    by Pal John Pal Adabala, Saeideh Shamsi Kazem Abadi, Oluwafemi Akintola, Sandeep Bhosale, Andrew J. Bennet

    Glycoside hydrolases (GHs) catalyze hydrolyses of glycoconjugates in which the enzyme choreographs a series of conformational changes during the catalytic cycle. As a result, some glycoside hydrolase families, including the α-amylases (GH13), have their chemical steps concealed kinetically. To address this issue for a GH13 enzyme we made seven cyclohexenyl-based carbasugars of α-D-glucopyranoside that we show are good covalent inhibitors of a GH13 yeast α-glucosidase. The linear free energy relationships between rate constants and pKa of the leaving group is curved upwards, which is indicative of a change in mechanism, with the better leaving groups reacting by a SN1 mechanism, while reaction rates for the worse leaving groups are limited by a conformational change of the Michaelis complex prior to a rapid SN2 reaction with the enzymatic nucleophile. Five bicyclo[4.1.0]heptyl-based carbaglucoses were tested with this enzyme, and our results are consistent with pseudo-glycosidic bond cleavage occurs via SN1 transition states that include non-productive binding of the leaving group to the enzyme. In total we show that the conformationally orthogonal reactions of these two carbasugars reveal mechanistic details hidden by conformational changes that the Michaelis complex of enzyme and natural substrate undergoes that aligns the nucleophile for efficient catalysis.


  • Open Access

    Revealing the mechanism for covalent inhibition of glycoside hydrolases by carbasugars at an atomic level

    by Weiwu Ren, Robert Pengelly, Marco Farren-Dai, Saeideh Shamsi Kazem Abadi, Verena Oehler, Oluwafemi Akintola, Jason Draper, Michael Meanwell, Saswati Chakladar, Katarzyna Świderek, et al.

    Mechanism-based glycoside hydrolase inhibitors are carbohydrate analogs that mimic the natural substrate’s structure. Their covalent bond formation with the glycoside hydrolase makes these compounds excellent tools for chemical biology and potential drug candidates. Here we report the synthesis of cyclohexene-based α-galactopyranoside mimics and the kinetic and structural characterization of their inhibitory activity toward an α-galactosidase fromThermotoga maritima(TmGalA). By solving the structures of several enzyme-bound species during mechanism-based covalent inhibition ofTmGalA, we show that the Michaelis complexes for intact inhibitor and product have half-chair (2H3) conformations for the cyclohexene fragment, while the covalently linked intermediate adopts a flattened half-chair (2H3) conformation. Hybrid QM/MM calculations confirm the structural and electronic properties of the enzyme-bound species and provide insight into key interactions in the enzyme-active site. These insights should stimulate the design of mechanism-based glycoside hydrolase inhibitors with tailored chemical properties.